Company: SHPH
Filing Date: 2025-02-26
Form Type: 8-K
Source: 0001493152-25-008306
Chunk: 0

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-02-26
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item
2.02 Results of Operations and Financial Condition.

On
February 26, 2025, Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation (the “ Company”), issued a press
release providing a corporate update in connection with the filing of its Annual Report on Form 10-K for the year ended December 31,
2024.

A
copy of the press release is attached as Exhibit 99.1 hereto and incorporated herein by reference.

In
accordance with General Instruction B.2 of Form 8-K, the information in this Item 2.02, including Exhibit 99.1, shall not be deemed “filed”
for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “ Exchange Act”), or otherwise subject
to the liabilities of that Section. Such information may be incorporated by reference in another filing under the Exchange Act or the
Securities Act of 1933, as amended, only if and to the extent that such subsequent filing specifically references such information.

Item
9.01. Financial Statements and Exhibits.

(d)
Exhibits.

  Exhibit      Description                                           
      No.                                                            
     10.1      Press                                                 
               Release dated February 26, 2025                       
 ─────────────────────────────────────────────────────────────────────
      104      Cover Page Interactive                                

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

  SHUTTLE PHARMACEUTICALS HOLDINGS, INC.                               
  By:                                         /s/                      
  Name:                                       Anatoly Dritschilo       
  Title:                                      Chief Executive Officer